Abbey Biopharma Corp Lexington, MA - 02421

Abbey Biopharma Corp is categorized under Commercial Biotechnical Research in Lexington, MA and active since 1993.

Abbey Biopharma Corp was established in 1993, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Sanj K at the company’s headquarters by writing to 33 Hayden Avenue # 1, Lexington, Massachusetts MA 02421 or by phoning (781) 357-9900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Abbey Biopharma Corp
Contact Person: Sanj K
Address: 33 Hayden Avenue # 1, Lexington, Massachusetts 02421
Phone Number: (781) 357-9900
Website Address: avigenics.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1993
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Abbey Biopharma Corp was started in 1993 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Sanj K for inquiries that concern Abbey Biopharma Corp by calling the company number (781) 357-9900, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Abbey Biopharma Corp can be found at the coordinates 42.425693,-71.249768 as well as the street address 33 Hayden Avenue # 1 in Lexington, Massachusetts 02421.

For its online presence, you may visit Abbey Biopharma Corp’s website at avigenics.com and engage with its social media outlets through on Twitter and on Facebook.